RNS Number : 0440P
Legal & General UCITS ETF PLC
04 June 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
04/06/2020 |
IE00BFXR5Q31 |
11767267 |
USD |
136897881.60 |
11.634 |
| L&G UK Equity UCITS ETF |
04/06/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
11268133.78 |
9.390 |
| L&G Global Equity UCITS ETF |
04/06/2020 |
IE00BFXR5S54 |
2900000 |
USD |
32700758.41 |
11.276 |
| L&G Japan Equity UCITS ETF |
04/06/2020 |
IE00BFXR5T61 |
10745000 |
USD |
113664407.86 |
10.578 |
| L&G Europe ex UK Equity UCITS ETF |
04/06/2020 |
IE00BFXR5V83 |
9260988 |
EUR |
99473733.15 |
10.741 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
04/06/2020 |
IE00BFXR5W90 |
4405639 |
USD |
45873683.51 |
10.412 |
| L&G Clean Water UCITS ETF |
04/06/2020 |
IE00BK5BC891 |
1450000 |
USD |
15584812.95 |
10.748 |
| L&G Artificial Intelligence UCITS ETF |
04/06/2020 |
IE00BK5BCD43 |
5500000 |
USD |
65223382.85 |
11.859 |
| L&G Healthcare Innovation UCITS ETF |
04/06/2020 |
IE00BK5BC677 |
2400000 |
USD |
29083326.70 |
12.118 |
| L&G Pharma Breakthrough UCITS ETF |
04/06/2020 |
IE00BF0H7608 |
2400000 |
USD |
28297280.54 |
11.791 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
04/06/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
94071359.94 |
10.225 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
04/06/2020 |
IE00BKLWY790 |
57400000 |
USD |
597709163.52 |
10.413 |
| L&G Battery Value-Chain UCITS ETF |
04/06/2020 |
IE00BF0M2Z96 |
13000000 |
USD |
121018505.59 |
9.309 |
| L&G Ecommerce Logistics UCITS ETF |
04/06/2020 |
IE00BF0M6N54 |
5150000 |
USD |
54089058.30 |
10.503 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
04/06/2020 |
IE00BMW3QX54 |
46630616 |
USD |
816824974.41 |
17.517 |
| L&G Cyber Security UCITS ETF |
04/06/2020 |
IE00BYPLS672 |
82636776 |
USD |
1513978499.38 |
18.321 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVGZGGVZDVGGZZ
